Evidence map›Paper›PMID 33446823›Full record

Trial reportScientific reports2021

In vivo multimodal optical imaging of dermoscopic equivocal melanocytic skin lesions.

V Elagin, E Gubarkova, O Garanina, D Davydova, N Orlinskaya, L Matveev, I Klemenova, I Shlivko, M Shirmanova, E Zagaynova

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Multiphoton FLIM Analyses of Native and UVA-Modified Synthetic Melanins.International journal of molecular sciences · 2023
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

V ElaginPrivolzhsky Research Medical University, Minin and Pozharsky Square 10/1, Nizhny Novgorod, Russia, 603950. elagin.vadim@gmail.com.
E GubarkovaPrivolzhsky Research Medical University, Minin and Pozharsky Square 10/1, Nizhny Novgorod, Russia, 603950.
O GaraninaPrivolzhsky Research Medical University, Minin and Pozharsky Square 10/1, Nizhny Novgorod, Russia, 603950.
D DavydovaNizhny Novgorod Regional Clinical Oncology Center, Delovaya Street, 11/1, Nizhny Novgorod, Russia, 603126.
N OrlinskayaPrivolzhsky Research Medical University, Minin and Pozharsky Square 10/1, Nizhny Novgorod, Russia, 603950.
L MatveevInstitute of Applied Physics of the Russian Academy of Sciences, Ulyanov Street 46, Nizhny Novgorod, Russia, 603950.
I KlemenovaPrivolzhsky Research Medical University, Minin and Pozharsky Square 10/1, Nizhny Novgorod, Russia, 603950.
I ShlivkoPrivolzhsky Research Medical University, Minin and Pozharsky Square 10/1, Nizhny Novgorod, Russia, 603950.
M ShirmanovaPrivolzhsky Research Medical University, Minin and Pozharsky Square 10/1, Nizhny Novgorod, Russia, 603950.
E ZagaynovaPrivolzhsky Research Medical University, Minin and Pozharsky Square 10/1, Nizhny Novgorod, Russia, 603950.
Privolzhsky Research Medical University · RUInstitute of Applied Physics · RUN. I. Lobachevsky State University of Nizhny Novgorod · RUNizhny Novgorod Regional Clinical Oncology Center · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a wide range of equivocal melanocytic lesions that can be clinically and dermoscopically indistinguishable from early melanoma. In the present work, we assessed the possibilities of combined using of multiphoton microscopy (MPM) and optical coherence angiography (OCA) for differential diagnosis of the equivocal melanocytic lesions. Clinical and dermoscopic examinations of 60 melanocytic lesions revealed 10 benign lesions and 32 melanomas, while 18 lesions remained difficult to diagnose. Histopathological analysis of these lesions revealed 4 intradermal, 3 compound and 3 junctional nevi in the "benign" group, 7 superficial spreading, 14 lentigo maligna and 11 nodular melanomas in the "melanoma" group and 2 lentigo simplex, 4 dysplastic nevi, 6 melanomas in situ, 4 invasive lentigo melanomas and 2 invasive superficial spreading melanomas in the "equivocal" group. On the basis of MPM, a multiphoton microscopy score (MPMS) has been developed for quantitative assessment of melanoma features at the cellular level, that showed lower score for benign lesions compare with malignant ones. OCA revealed that the invasive melanoma has a higher vessel density and thicker blood vessels than melanoma in situ and benign lesions. Discriminant functions analysis of MPM and OCA data allowed to differentiate correctly between all equivocal melanocytic lesions. Therefore, we demonstrate, for the first time, that a combined use of MPM and OCA has the potential to improve early diagnosis of melanoma.

Indexed as

Intravital MicroscopyMelanomaMicroscopy, Fluorescence, MultiphotonSkin NeoplasmsCutaneous Malignant MelanomaFemaleHumansMaleNevus, Pigmented

Identifiers

PMID33446823
PMCPMC7809210
OpenAlexW3125619645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.